BVT Aktienanleihe MRK 28.06.2024/ DE000VU779P7 /
2024-06-07 8:56:28 AM | Chg.-0.02 | Bid1:05:03 PM | Ask1:05:03 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
99.87EUR | -0.02% | 99.87 Bid Size: 500,000 |
- Ask Size: - |
MERCK KGAA O.N. | 152.60 EUR | 2024-06-28 | Call |
GlobeNewswire
06-06
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimo...
GlobeNewswire
06-03
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
GlobeNewswire
05-29
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA